<DOC>
	<DOCNO>NCT01983657</DOCNO>
	<brief_summary>The purpose study establish efficient economic treatment scheme evaluation safety efficacy subcutaneous injection low-dose rhGM-CSF , similar injection whole lung lavage , patient PAP .</brief_summary>
	<brief_title>Study Subcutaneous Injection Low-dose rhGM-CSF +/- WLL PAP .</brief_title>
	<detailed_description>The purpose study establish efficient economic treatment scheme evaluation safety efficacy subcutaneous injection low-dose rhGM-CSF , similar injection whole lung lavage , patient PAP . During observation , study visit occur end month . During 1-year follow-up period last 6 month treatment , participant require check various efficacy indicator .</detailed_description>
	<mesh_term>Pulmonary Alveolar Proteinosis</mesh_term>
	<criteria>Diagnosed PAP patient Aged 1780 Signed inform consent Secondary PAP Received whole lung lavage therapy within 4 week enrollment Received previous GMCSF therapy within 6 month enrollment WBC≥12,000/ul fever≥38℃ Severe edema , severe liver , kidney , lung cardiovascular disease . Pregnant，planning get pregnant nursing Inability express subjective discomfort Serious drug allergy history , E.coli preparation rhGMCSF serious allergy history</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Pulmonary</keyword>
	<keyword>Pulmonary Alveolar Proteinosis</keyword>
	<keyword>PAP</keyword>
</DOC>